WashU Medicine Endocrinology

06/18/2026

Intriguing findings from senior author Dr. Maria Remedi and colleagues examine biological changes that may contribute to the declining effectiveness of sulfonylurea therapy in type 2 diabetes: bit.ly/4aYw5T3.

Maria S. Remedi, PhD Maria S. Remedi, PhD, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, is the senior author of an article published Fe…

06/17/2026

We have many core service centers, such as the Core Lab for Clinical Studies, the Diabetes Research Center, the Mass Spectrometry and Lipidomics Core, and Metabolomics. Learn more about them at https://bit.ly/4h1UdF2.

06/16/2026

Please join us in congratulating Dr. Sina Jasim on earning the FACE (Fellow of the American Association of Clinical Endocrinology) designation and on her appointment to the American Association of Clinical Endocrinology Board of Directors.
These prestigious achievements recognize Dr. Jasim’s outstanding contributions to endocrinology, as well as her leadership and commitment to advancing patient care and the specialty. We celebrate this well-deserved recognition and look forward to her continued impact in the field.

06/12/2026

We're proud to recognize our faculty and fellows who represented our division at the American Association of Clinical Endocrinology's Annual Meeting 2026, one of the leading gatherings for endocrinology professionals nationwide.

Our team contributed through invited lectures, research presentations, professional discussions, and clinical case studies:

• Dr. Sina Jasim gave the lecture titled "Minimally Invasive Management of Thyroid Nodules."

• Dr. Julie Silverstein delivered an oral presentation titled "Long-term Safety and Efficacy of Lonapegsomatropin in Adults With Growth Hormone Deficiency: Results From a 52-Week Open-Label Extension Trial" and presented an e-poster titled "Relacorilant Treatment Improves Glycemic Control Among Individuals With Endogenous Hypercortisolism and Hyperglycemia on Glucagon-Like Peptide-1 Receptor Agonists: Insights From a Phase 3 Study."

• Dr. Amy Riek participated in the AACE professional development talk show titled "Triaging Endocrine Referrals: Tackling the Access Dilemma."

• Dr. Dipika Mohan delivered an oral abstract presentation titled "Molecular Characterization of Upper Pole Thyroid Nodules" and presented an e-poster titled "Trends in Clinical Management of Patients With Pheochromocytoma/Paraganglioma: An AACE-Supported Physician Survey."

• Dr. Emily Bussan presented a case study e-poster titled "A Rare Finding of Thyroid Nocardiosis in an Immunocompromised Patient."

Congratulations to our faculty and fellows on their outstanding contributions and achievements.

06/10/2026

Clinical research is essential to advancing patient care and developing innovative therapies, diagnostic tools, and medications. To learn more about our ongoing studies and current volunteer opportunities, please visit: http://bit.ly/427elza.

06/09/2026

Dr. Clair Crewe, lead author of a new study in Cell Press, uncovers how obesity disrupts the body's cellular messaging system. The findings suggest that impaired clearance of fat-cell extracellular vesicles may contribute to reduced insulin sensitivity and metabolic disease: bit.ly/4oiNI5G.

Clair Crewe, PhD Lead author Clair Crewe, PhD, Assistant Professor of Medicine in WashU Medicine’s Division of Cell Biology and Physiology and Division of Endocrinology, Metabolism and&nb…

06/08/2026

From diabetes to thyroid disorders, our specialized endocrine and metabolic care centers support patients every step of the way.
Expert care. Personalized treatment. Better outcomes.
Explore our locations and services: bit.ly/3MdYuGC.

06/05/2026

This week, we had the pleasure of celebrating our fellows at a farewell dinner, recognizing their dedication, hard work, and many contributions throughout their time with us. Thank you for everything, and congratulations on this next chapter. We wish you continued success!

06/03/2026

In case you missed it, check out our May e-newsletter to read about the latest that we've been up to: bit.ly/4o575iB.
Sign up to receive our monthly e-newsletters at: bit.ly/4l8jU9T.

06/02/2026

Congratulations to Dr. Jeffrey R. Millman on receiving funding from Breakthrough T1D to advance scalable stem cell-islet therapies for type 1 diabetes. His research aims to overcome key manufacturing barriers and to help bring high-quality, stem cell-derived islet therapies closer to patients living with type 1 diabetes: https://bit.ly/4dJob1T.

Jeffrey R. Millman, PhD, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, has received research funding from Breakthrough T1D&nbs…